Exchange: OTC·Updated 02:22 PM EDT

BIOYF BioSyent Inc.

$11.25
$0.01
(0.09%)
Today
EarningsNov 19
Mkt Cap$128.68M
Vol550.00

About BIOYF

BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include Cathejell Jelly, FeraMAX Pd Therapeutic 150, FeraMAX Pd Powder 15, Proktis-M, RepaGyn, and cTIBELLA. The company was founded on April 28, 1947 and is headquartered in Mississauga, Canada.
50

Neutral Sentiment

How do you feel about BIOYF?

Advertisement|Remove ads.